There is a reason why Healthlinx has only had $6k of sales in the last 6 months.
Healthlinx doesn't have intellectual property! Their patent is rubbish as it covers a mathematical algorithm around the biomarkers. The problem is that there is a public study from the US. Also the FDA removed the use of this test as it wasn't valide enough. The problem is false positives. If you tell a lady she has ovarian cancer from this test, she goes and gets her ovaries removed but the test was a false positive it opens for a large lawsuit. In the UK there was a case won by a person with a prostate cancer diagnosis. He spent all of his money thinking he had only 6 months left to go and had his prostate removed to only find out that the diagnosis was a false positive.
Any public published study negates an attempt to grant a patent. Also Healthlinx works by a panel of 5 biomarkers including CA125, which can't be patented. I will repeat biomarkers can't be patented.
Dr. Mor is the leader in this field and will have a diagnostic ready over the next 5 years.
See how the FDA banned this diagnostic, the same unpatentable technology as Healthlinx http://www.efluxmedia.com/news_FDA_Warns_LabCorp_Over_Illegal_Sales_Of_Ovarian_Cancer_Test_26167.html
HTX Price at posting:
11.5¢ Sentiment: Sell Disclosure: Not Held